Angiochem has been making news since its founding in 2003. Watch this page for recent stories on Angiochem and EPiC Technology.
Prof Tang speaks with ecancertv at ESMO 2016 about successes with ANG1005, a conjugate of paclitaxel with a peptide which can cross the blood brain barrier.
Watch the video.
Le Code Chastenay is a TV show specializing in awareness and science popularization. In this show, they explain the science behind Angiochem technology.
The TV show Découverte at Radio-Canada, national canadien television, presents the brain and issues in treating brain diseases including brain cancer.
Angiochem was named by Fierce Biotech one of the “Fierce 15” biotech companies of 2012 for its innovation in biotechnology.
Read the article
Angiochem was presented with the Innovation Recognition Award from the National Brain Tumor Society for its progress in developing novel treatments for brain tumors that are capable of crossing the blood-brain barrier.
Read the news release
The reputable Montreal daily newspaper showcases Angiochem’s work in developing treatments for brain cancer and brain-related diseases in its Innovation section.